Lv1
30 积分 2025-07-25 加入
Abstract CT075: Updated overall survival outcomes from a randomized, double-blind phase III study of sintilimab versus placebo in combination with chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma (ORIENT-15)
11个月前
已关闭
Efficacy and safety evaluation of first-line systemic treatments for unresectable esophageal squamous cell carcinoma: a network meta-analysis
11个月前
已完结
Structural characteristics and SARs of EZH2 inhibitors
11个月前
已完结
An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma
11个月前
已完结
Luminal and Basal Subtypes of Metastatic Prostate Cancer
11个月前
已完结
Analysis of risk signals for Viloxazine in the treatment of attention deficit hyperactivity disorder based on the FAERS database
11个月前
已完结
皖公网安备34019202002308
